Home > Drug Search >
  • company_query: BN ImmunoTherapeutics
  •   > 
Drug Filter
Category:
chemistry (6) biology (51)
Status:
Approved (10) Phase Ⅲ (13) Phase Ⅱ (20) Phase Ⅰ (11) IND Filing (3)
Clinical Stage:
Pending (4) Active (35) Discontinued (8)
Bio-Type:
Gene therapy (2) Vaccine (10) Allergen extract (2) Recombinant cytokines (9) Whole antibody (17) ADC (1) Fusion protein (5)
Indication:
Acute myeloid Leukemia (AML) (2) Allergic rhinitis (AR) (1) Allergic rhinoconjunctivitis (2) Anemia (4) Atopic dermatitis (1) Bladder cancer (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (1) Constipation (1) Rheumatic disorders (1) Gastric cancer (1) Cytomegalovirus infections (1) HBV infection (2) Timothy grass pollen-induced allergic rhinitis (1) Inflammatory bowel disease (2) Somatotropin deficiency (1) Melanoma (2) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (4) Non-Hodgkin’s lymphoma (NHL) (2) Osteoarthritis (OA) (1) Pancreatic cancer (2) Ectodermal dysplasia (1) Postmenopausal osteoporosis (1) Prostate cancer (3) Psoriasis (1) Rheumatoid arthritis (RA) (6) Solid tumours (3) Systemic lupus erythematosus (1) Ulcerative colitis (1) Cervical intraepithelial neoplasia (1) Colorectal cancer (2) Cryopyrin-Associated Periodic Syndromes (CAPS) (1) Age-related macular degeneration (AMD) (1) Pain (1) Diabetes (1) Bone metastases from solid tumors (1) HER2-positive metastatic breast cancer (1) Malaria (2) Neutropenia (5) Renal carcinoma (1) Peritoneum cancer (1) Lupus nephritis (1) Allergic asthma (1) HER2-positive breast cancer (1) Liver cancer (1) Metabolic Syndrome X (1) Giant cell tumor of bone (1) Hypersensitivity (4)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top